397 related articles for article (PubMed ID: 35284045)
1. Development of rapid antigen test prototype for detection of SARS-CoV-2 in saliva samples.
Kivrane A; Igumnova V; Liepina EE; Skrastina D; Leonciks A; Rudevica Z; Kistkins S; Reinis A; Zilde A; Kazaks A; Ranka R
Ups J Med Sci; 2022; 127():. PubMed ID: 35284045
[TBL] [Abstract][Full Text] [Related]
2. Point of care detection of SARS-CoV-2 antibodies and neutralisation capacity-lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance practices.
McGrath J; O'Doherty L; Conlon N; Dunne J; Brady G; Ibrahim A; McCormack W; Walsh C; Domegan L; Walsh S; Kenny C; Allen N; Fleming C; Bergin C
Front Public Health; 2023; 11():1245464. PubMed ID: 37841735
[TBL] [Abstract][Full Text] [Related]
3. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
[TBL] [Abstract][Full Text] [Related]
5. Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
Arinola OG; Edem VF; Rahamon SK; Yaqub SA; Fashina AO; Alonge TO
Niger J Physiol Sci; 2020 Dec; 35(2):117-121. PubMed ID: 34009193
[TBL] [Abstract][Full Text] [Related]
6. Development of robust, indigenous ELISA for detection of IgG antibodies against CoV-2 N and S proteins: mass screening.
Srivastava AK; Gupta A; Chauhan D; Meena RC; Sugadev R; Eslavath MR; Gupta H; Karuna ; Singh S; Singh Y; Tiwari RP; Kohli V; Varshney R; Ganju L
Appl Microbiol Biotechnol; 2022 Sep; 106(18):6225-6238. PubMed ID: 35976427
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of time-resolved fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike antigen.
Xu B; Tang H; Weng Y; Jones VS; Luo S; Cho CY; Lin Y; Fang J; Song X; Huang RP
J Clin Lab Anal; 2022 Jul; 36(7):e24513. PubMed ID: 35692032
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
[TBL] [Abstract][Full Text] [Related]
9. Assessment of specific human antibodies against SARS-CoV-2 receptor binding domain by rapid in-house ELISA.
Hussein NA; Ali EAA; El-Hakim AE; Tabll AA; El-Shershaby A; Salamony A; Shaheen MNF; Ali I; Elshall M; Shahein YE
Hum Antibodies; 2022; 30(2):105-115. PubMed ID: 35431235
[TBL] [Abstract][Full Text] [Related]
10. Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects.
Zhang P; Li B; Wang Y; Min W; Wang X; Zhou Y; Li Z; Zhao Y; Zhang H; Jiang M; Zheng H; Yang C; Zhang W; Zuo L; Gao Q; Yang Z; Li Y; Feng T; Lin C; Hu Q; Song T; Yang R
BMC Microbiol; 2022 Feb; 22(1):42. PubMed ID: 35114938
[TBL] [Abstract][Full Text] [Related]
11. Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer.
Chan CW; Yi X; Lenza M; Baldwin AD; Jakalski J; Tesic V; Yeo KJ
Am J Clin Pathol; 2022 Jan; 157(1):109-118. PubMed ID: 34463315
[TBL] [Abstract][Full Text] [Related]
12. A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2.
Salem R; Elshamy AM; Kamel N; Younes S; Marie OM; Waly FR; El-Kholy AA; Elmenofy W
Biotechnol Lett; 2022 Dec; 44(12):1507-1517. PubMed ID: 36319880
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants.
Morinaga Y; Tani H; Terasaki Y; Nomura S; Kawasuji H; Shimada T; Igarashi E; Saga Y; Yoshida Y; Yasukochi R; Kaneda M; Murai Y; Ueno A; Miyajima Y; Fukui Y; Nagaoka K; Ono C; Matsuura Y; Fujimura T; Ishida Y; Oishi K; Yamamoto Y
Microbiol Spectr; 2021 Dec; 9(3):e0056021. PubMed ID: 34851163
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms.
Turbett SE; Anahtar M; Dighe AS; Garcia Beltran W; Miller T; Scott H; Durbin SM; Bharadwaj M; Thomas J; Gogakos TS; Astudillo M; Lennerz J; Rosenberg ES; Branda JA
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33020186
[TBL] [Abstract][Full Text] [Related]
15. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination.
Fresco-Taboada A; García-Durán M; Aira C; López L; Sastre P; van der Hoek L; van Gils MJ; Brouwer PJM; Sanders RW; Holzer B; Zimpernikc I; López-Collazo E; Muñoz P; Rueda P; Vela C
Diagn Microbiol Infect Dis; 2022 Apr; 102(4):115650. PubMed ID: 35218991
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.
Huynh A; Arnold DM; Smith JW; Moore JC; Zhang A; Chagla Z; Harvey BJ; Stacey HD; Ang JC; Clare R; Ivetic N; Chetty VT; Bowdish DME; Miller MS; Kelton JG; Nazy I
Viruses; 2021 Apr; 13(4):. PubMed ID: 33923828
[TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of homemade ELISA and lateral flow assay (LFA)in the rapid, specific and sensitive detection of SARS-CoV-2 anti-nucleocapsid protein in sera of Egyptian patients.
El-Shershaby A; Hussein N; Ali E; El-Hakim A; Tabll A; Shaheen M; Ali I; Elshall M; Shahein Y
J Immunoassay Immunochem; 2023 Jul; 44(4):338-359. PubMed ID: 37319429
[TBL] [Abstract][Full Text] [Related]
19. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
Isho B; Abe KT; Zuo M; Jamal AJ; Rathod B; Wang JH; Li Z; Chao G; Rojas OL; Bang YM; Pu A; Christie-Holmes N; Gervais C; Ceccarelli D; Samavarchi-Tehrani P; Guvenc F; Budylowski P; Li A; Paterson A; Yue FY; Marin LM; Caldwell L; Wrana JL; Colwill K; Sicheri F; Mubareka S; Gray-Owen SD; Drews SJ; Siqueira WL; Barrios-Rodiles M; Ostrowski M; Rini JM; Durocher Y; McGeer AJ; Gommerman JL; Gingras AC
Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33033173
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
